Nuveen Core Plus Bond ETF (NASDAQ:NCPB – Get Free Report) saw a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 12,500 shares, a drop of 22.8% from the October 15th total of 16,200 shares. Based on an average daily volume of 6,700 shares, the days-to-cover ratio is currently 1.9 days.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Nuveen Core Plus Bond ETF stock. Daymark Wealth Partners LLC boosted its holdings in shares of Nuveen Core Plus Bond ETF (NASDAQ:NCPB – Free Report) by 37.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 480,830 shares of the company’s stock after buying an additional 130,361 shares during the quarter. Daymark Wealth Partners LLC owned approximately 24.04% of Nuveen Core Plus Bond ETF worth $12,470,000 as of its most recent SEC filing.
Nuveen Core Plus Bond ETF Price Performance
Shares of NCPB stock traded down $0.04 during mid-day trading on Friday, hitting $25.03. The stock had a trading volume of 124 shares, compared to its average volume of 132,344. Nuveen Core Plus Bond ETF has a 12-month low of $24.40 and a 12-month high of $26.08. The firm’s 50-day moving average is $25.55 and its two-hundred day moving average is $25.28.
Nuveen Core Plus Bond ETF Increases Dividend
About Nuveen Core Plus Bond ETF
The Nuveen Core Plus Bond ETF (NCPB) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund is active, investing in a diversified mix of high-quality and below investment grade securities to optimize returns and manage risks. NCPB was launched on Mar 5, 2024 and is issued by Nuveen.
Further Reading
- Five stocks we like better than Nuveen Core Plus Bond ETF
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Are Penny Stocks a Good Fit for Your Portfolio?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Trading Halts Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Nuveen Core Plus Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuveen Core Plus Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.